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Abstract
The additive consists of single strains of Bacillus subtilis and Aspergillus oryzae, to be used in combination
as a technological additive (proposed functional group: Substances for the reduction of anti-nutritional
factors) in feed materials for all animal species. An opinion on the two microorganisms was published
previously. At this time, the safety of the B. subtilis strain for target animals, consumers, users and the
environment was established, but no conclusions could be draw on the safety of the strain of A. oryzae for
the target species and consumers or on the efﬁcacy of the additive in reducing anti-nutritional factors.
This opinion considers new information intended to address the identiﬁed deﬁciencies in the previous
opinion. An extensive analytical search for secondary metabolites was made of the A. oryzae component
of the additive and 15 metabolites were detected and quantiﬁed. Of the 15 metabolites, 13 occurred in
ng/g additive concentrations and were considered not to be of concern. The remaining two compounds,
cyclic dipeptides (2,5-diketopiperazines), were detected at concentrations up to 1.5 mg/kg. Both have
been identiﬁed in a wide range of foods and beverages and there appears to be no reports of adverse
reactions to such cyclic dipeptides in processed food. Consequently, none of the metabolites detected
were considered likely to cause adverse effects in target animals fed treated feed material or in
consumers of products derived from such animals. Data from the analysis of 18 batches of soybean
before and after treatment with the two strains were presented in support of the efﬁcacy of the additive.
Two classes of anti-nutritional factors were considered; oligosaccharides of the rafﬁnose series and
trypsin inhibitor. The microbial strains in combination were able to substantially reduce the concentration
of oligosaccharides and trypsin inhibitor naturally present in soybean. Other feed materials were not
considered.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Regulation (EC) No 1831/2003 establishes rules governing the Community authorisation of additives
for animal nutrition and, in particular, Article 9 deﬁnes the terms of the authorisation by the
Commission.
The applicant, Regal BV on behalf of Nutraferma Co., is seeking a Community authorisation of
Bacillus subtilis GR-101, Aspergillus oryzae GB-107 to be used as feed additives. (Table 1)
On 8 September 2015, the Panel on Additives and Products or Substances used in Animal Feed of
the European Food Safety Authority (‘Authority’), in its opinion on the safety and efﬁcacy of the
product concluded that the additive Aspergillus oryzae KCTC 10258BP and Bacillus subtilis KCCM
10673P were insufﬁciently characterised. So, in the absence of data on production of toxic secondary
metabolites in A. oryzae, the FEEDAP Panel couldn’t draw conclusions on its safety for the target
species and consumers of products and tissues derived from animals fed the additive. In addition, the
FEEDAP Panel couldn’t draw conclusions on the efﬁcacy of the additive.
The Commission, after the consultation with the Member States at the Standing Committee on
Plants, Animals, Food and Feed, decided to give the possibility to the applicant to submit
complementary information in order to complete the assessment on the safety and efﬁcacy and to
allow a revision of Authority’s opinion.
The Commission has now received new data on the safety and efﬁcacy of Bacillus subtilis GR-101
and Aspergillus oryzae GB-107.
In view of the above, the Commission asks the Authority to deliver a new opinion on the safety and
efﬁcacy of Bacillus subtilis GR-101 and Aspergillus oryzae GB-107 as a feed additive based on the
additional data submitted by the applicant.
1.2. Additional information
In 2009, the European Food Safety Authority (EFSA) was requested by the European Commission
to evaluate a product consisting of two microbial strains (B. subtilis and A. oryzae) intended to be
used to treat soybean and other feed materials to reduce the concentration of anti-nutritional factors.
An opinion on the assessment of the two organisms as a technological additive in a proposed new
functional group of ‘substances for the reduction of anti-nutritional factors’ for all animal species was
published in 2015 (EFSA FEEDAP Panel, 2015). The safety of the B. subtilis strain for target animals,
consumers, users and the environment was established, but no conclusions could be draw on the
safety of the strain of A. oryzae for the target species and the consumer. The FEEDAP Panel also was
unable to establish the efﬁcacy of the additive in reducing anti-nutritional factors in soybean and other
feed materials.
2. Data and Methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of additional
information1 to a previous application on the same product.2
Table 1: Description of the substances
Category of additive Technological additives
Functional group of
additive
Substances for the reduction of anti-nutritional factors:
substances or, where applicable microorganisms which reduce or remove anti-
nutritional factors from feed (in accordance with SANTE reference: 3933683)
Description Bacillus subtilis GR-101 and Aspergillus oryzae GB-107
Target animal category All animal species
Applicant Regal BV on behalf of Nutraferma Co.
Type of request New opinion
1 FEED dossier reference: FAD-2016-0014.
2 FEED dossier reference: FAD-2009-0007.
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of B. subtilis and
A. oryzae is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant
guidance documents: Guidance on technological additives (EFSA FEEDAP Panel, 2012a), Guidance for
establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b) and Guidance on
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c).
3. Assessment
The additive consists of single strains of B. subtilis and A. oryzae, to be used in combination as a
technological additive (proposed new functional group: Substances for the reduction of anti-nutritional
factors) in feed materials for all animal species.
3.1. Characterisation
3.1.1. Characterisation of the active agents
Bacillus subtilis
The strain is deposited in the Korean Culture Center of Microorganisms with the accession number
KCCM 10673P. The identity of the strain, its susceptibility to antibiotics and its toxigenic potential were
considered in the previous opinion and no concerns were identiﬁed.
Aspergillus oryzae
The strain is deposited in the Korean Culture Center of Microorganisms with the accession number
KCTC 10258BP. Data relating to strain identity was provided in the context of the previous opinion and
considered satisfactory. Evidence of the absence of genes involved in the production of aﬂatoxin was
also provided at that time. However, there was no information on the presence of other secondary
metabolites of concern known to occur in some strains of A. oryzae. This issue has now been
addressed by the applicant.
It was conﬁrmed that the strain was isolated from a Korean traditional food (Meju, fermented soy
paste). In an initial screen, the A. oryzae preparation derived from the solid substrate fermentation
and used to treat the feed material (described as the seed culture) was examined for the presence of
selected compounds of recognised concern, as described by Blumenthal (2004).3 Although the species
speciﬁc mycotoxins kojic acid, 3-nitropropionic acid and cyclopiazonic acid or the antibiotic penicillin G
(benzylpenicillin) were not detected, the high-performance liquid chromatography (HPLC) ﬁngerprint
method employed had limited sensitivity. Subsequently, a far more extensive analysis of secondary
metabolites of possible toxicological relevance was made of three batches using liquid chromatography
with tandem mass spectrometry (LC–MS/MS). A battery of nearly 200 metabolites was considered.4
The limit of detection (LOD) for each metabolite, individually determined using stock multianaylate
solutions, were generally < 10 lg/kg. Using this method a total of 15 metabolites was detected and
quantiﬁed (Table 2).
Table 2: Mean concentrations (lg/kg sample) of metabolites identiﬁed in the A. oryzae preparation
derived from the solid substrate fermentation
Metabolite Concentration (lg/kg sample)
Zearalenone 0.7
Enniatin A 0.2
Enniatin A1 1.1
Enniatin B 0.6
Enniatin B1 1.7
Enniatin B2 0.1
Beauvericin 1.0
Culmorin 9.5
3 Technical dossier/ Annex A CoA Secondary metabolites Aspergillus.
4 Technical dossier/Supplementary Information October 2016 and Supplementary Information November 2016.
B. subtilis GR-101 and A. oryzae GB-107 for all animal species
www.efsa.europa.eu/efsajournal 5 EFSA Journal 2018;16(5):5275
Several of the metabolites detected, such as zeralenone, members of the enniatin family and
culmorin are associated with other fungal species, particularly Fusarium spp., and may have derived
from the contamination of the soybean used in production.
3.1.2. Characterisation of the additive
The methods used for the production of each of the two cultures were described in the previous
application and counts provided for ﬁve batches of each culture. The applicant has now deﬁned a
minimum speciﬁcation for each culture allowing the conditions of use to be more precisely deﬁned:
B. subtilis culture: minimum content 1.2 9 108 CFU/g compared to a mean for the ﬁve batches of
4.3 9 108 CFU/g (range 3.7–5.3 9 108 CFU/g).
A. oryzae culture: minimum content 2.0 9 108 CFU/g compared to a mean for the ﬁve batches of
2.7 9 108 CFU/g (range 2.2–3.0 9 108 CFU/g).
No data has been provided on microbiological or chemical impurities of the additive other than the
new data provided for A. oryzae.
3.1.3. Conditions of use
In the original application, it is stated that there is no intention to make the two microbial cultures
available to feed manufacturers or to farmers. They will be used only by the applicant to treat feed
materials for eventual sale.
The two cultures are combined at the point of application with a total inclusion rate of 20 g/kg feed
material on a 50:50 basis by weight delivering a minimum of 1.2 9 106 CFU B. subtilis and
2.0 9 106 CFU A. oryzae/kg feed material.
3.2. Safety
3.2.1. Safety for the target species, the consumer and the environment
In the previous opinion (EFSA FEEDAP Panel, 2015), it was concluded that the strain of B. subtilis met
the criteria required for the Qualiﬁed Presumption of Safety (QPS) approach to safety assessment (EFSA
BIOHAZ Panel, 2017) to be applied. On this basis, the strain was presumed safe for target species, the
consumers of products derived from animals exposed to the bacterium and for the environment. The
safety of A. oryzae for the environment was also already established in the previous opinion.
Strains of A. oryzae have a long and extensive history of use in the production of foods from
soybean and the strain involved in this application was isolated from one such food item. An extensive
search for potentially toxic metabolites derived directly from the metabolism of the A. oryzae strain or
from the soybean on which it was grown identiﬁed a total of 15 metabolites/mycotoxins (Table 2). Of
the 15 compounds, 13 occurred at concentrations below 15 lg/kg. Although most are known to be
biologically active and have been tested for various pharmacological properties, toxicological studies
generally are absent. However, application of the Threshold of Toxicological Concern (TTC) approach to
all 13 compounds indicates a lack of concern for either target animals or consumers regardless of the
Cramer class applied.
The remaining two compounds (Cyclo (L-Pro-L-Tyr) and Cyclo (L-Pro-L-Val)) both cyclic dipeptides
(2,5-diketopiperazines), were detected at concentrations up to 1.5 mg/kg. Cyclic dipeptides are widely
distributed in nature and are naturally produced by both microorganisms and by mammals. They are
also found in many protein-rich processed foods, particularly when heat-processed, often contributing
to the sensory properties. They are also recognised as common by-products of fermentation by yeasts
and bacteria (see Review by Borthwick and Da Costa, 2017 and references therein). The two peptides
Metabolite Concentration (lg/kg sample)
3-Nitropropionic acid 1.8
Alternariaiol-monomethyl-ether 0.2
Emodin 1.9
Asperglaucide 5.6
Neoechinulin A 14.7
Cyclo (L-pro-L-tyr) 1,533
Cyclo (L-pro-L-val) 881
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in Table 2 have been identiﬁed in a wide range of foods and beverages including bread, beer, cheese
and Parma ham. There appear to be no reports of adverse reactions to cyclic dipeptides found in
processed food.
The FEEDAP Panel considers that the detected metabolites occur at concentrations considered
unlikely to cause adverse effects in target animals fed the treated feed material or in consumers of
products derived from such animals.
3.2.2. Safety for the user
In the previous opinion, the Panel concluded that the additive should be considered to be a skin
and eye irritant and a skin and respiratory sensitiser. No new data have been submitted, and therefore
the previous conclusions still apply.
3.3. Efﬁcacy
The additive is intended to be used reduce anti-nutritional factors concentration in feedingstuffs for
all animal species. In particular, the additive is applied to soybean to reduce the concentration of
anti-nutritional factors, through a solid state fermentation with Bacillus subtilis GR-101 and Aspergillus
oryzae GB-107
Data from the analysis of 18 batches of soybean before and after treatment with the two microbial
strains were presented in support of the efﬁcacy of the additive.5 The soybean samples were inoculated
according to the proposed conditions of use: 20 g additive/kg feed, corresponding to a minimum of
1.2 9 106 CFU of B. subtilis/kg feed) and a minimum of 2 9 106 CFU of A. oryzae/kg feed). After
inoculation, the soybean samples were deposited onto solid state fermentation beds with controlled air-
ﬂow and temperature. At the end of the fermentation period, the samples were dried and analysed. Two
classes of anti-nutritional factors were considered: oligosaccharides of the rafﬁnose series (rafﬁnose and
stachyose) and trypsin inhibitor.6
The mean content of rafﬁnose in the 18 samples of untreated soybean was 1.47% dry matter (DM)
(range 0.51–2.51% DM) and the mean content of stachyose was 6.11% DM (range 5.3–7.2% DM).
Treatment of the soybean left only residual amounts of the two oligosaccharides in all cases. The
content of rafﬁnose fell to a mean of 0.02% DM (range 0–0.08% DM) and stachyose to 0.05% DM
(range 0–0.1% DM). Similar result was seen with the trypsin inhibitor with the mean initial value of 2.9
trypsin inhibitor unit (TIU)/g (range 2.5–3.8 TIU/g) reducing by approximately 85% to a mean of 0.43
TIU/g (range 0.3–0.5 TIU/g).
No data was provided on other anti-nutritional factors or with feed materials other than soybean.
4. Conclusions
In the previous opinion, it was concluded that the strain of B. subtilis met the criteria required for
the QPS approach to safety assessment to be applied. On this basis, the strain was presumed safe for
target species and consumers of products derived from animals exposed to the bacterium.
The strain of A. oryzae has been exhaustively tested for the presence of secondary metabolites of
potential concern. Those metabolites detected occur at concentrations considered unlikely to cause
adverse effects in target animals fed the treated feed material or in consumers of products derived.
No new data have been submitted that modify the previous conclusions that the additive should be
considered to be a skin and eye irritant and a skin and respiratory sensitiser.
Both organisms are ubiquitous in nature. Their use as a technological additive is not expected to
pose a risk for the environment.
The two strains in combination, applied according to the conditions of use (minimum
1.2 9 106 CFU of B. subtilis/kg feed and minimum 2 9 106 CFU of A. oryzae/kg feed) are able to
substantially reduce the concentration of oligosaccharides of the rafﬁnose series and trypsin inhibitor
naturally present in soybean. Other feed materials have not been considered.
Documentation provided to EFSA
1) Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP for all animal species.
February 2016. Submitted by Nutraferma Co.
5 Technical dossier/Annexes 1–18.
6 Analysed according to AOCS Ofﬁcial Method Ba 12-75.
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2) Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP for all animal species.
Supplementary Information October 2016. Submitted by Nutraferma Co.
3) Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP for all animal species.
Supplementary Information November 2016. Submitted by Nutraferma Co.
4) Bacillus subtilis KCCM 10673P and Aspergillus oryzae KCTC 10258BP for all animal species.
Supplementary Information July 2017. Submitted by Nutraferma Co.
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Abbreviations
CFU colony forming unit
DM dry matter
FEEDAP Panel on Additives and Products or Substances used in Animal Feed
HPLC high-performance liquid chromatography
LC–MS/MS liquid chromatography with tandem mass spectrometry
LOD limit of detection
QPS Qualiﬁed Presumption of Safety
TIU trypsin inhibitor unit
TTC Threshold of Toxicological Concern
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